ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-6.99%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$309M
AUM Growth
+$309M
(+3.2%)
Cap. Flow
+$30M
Cap. Flow
% of AUM
9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.34%
Holding
93
New
15
Increased
35
Reduced
30
Closed
7
Top Buys
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$7.31M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$6.89M |
| 3 |
Elevance Health
ELV
|
$5.3M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$4.81M |
| 5 |
Boston Scientific
BSX
|
$4.71M |
Top Sells
| 1 |
AbbVie
ABBV
|
$4.61M |
| 2 |
Medtronic
MDT
|
$4.41M |
| 3 |
Viatris
VTRS
|
$4.39M |
| 4 |
Zimmer Biomet
ZBH
|
$4.23M |
| 5 |
Abbott
ABT
|
$3.97M |
Sector Composition
| 1 | Healthcare | 83.88% |
| 2 | Financials | 3.47% |
| 3 | Industrials | 1.36% |
| 4 | Technology | 0.14% |
| 5 | Consumer Staples | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
51
DELISTED
Celgene Corp
CELG
| $1.43M | 0.46% |
14,280
-12,400
| -46% | -$1.24M |
|
52
CONMED
CNMD
$1.64B
| $1.18M | 0.38% |
+28,090
| New | +$1.18M |
|
53
Penumbra
PEN
$10.5B
| $1.14M | 0.37% |
+24,700
| New | +$1.14M |
|
|
MDVN
54
DELISTED
MEDIVATION, INC.
MDVN
| $1.06M | 0.34% |
23,100
+11,600
| +101% | +$533K |
|
|
RAD
55
DELISTED
Rite Aid Corporation
RAD
| $995K | 0.32% |
6,105
-1,253
| -17% | -$204K |
|
56
CVS Health
CVS
$93B
| $882K | 0.29% |
8,500
-16,400
| -66% | -$1.7M |
|
|
57
Abbott
ABT
$230B
| $840K | 0.27% |
20,084
-94,900
| -83% | -$3.97M |
|
58
Amgen
AMGN
$153B
| $840K | 0.27% |
+5,600
| New | +$840K |
|
59
Charles River Laboratories
CRL
$7.99B
| $827K | 0.27% |
10,888
+2,300
| +27% | +$175K |
|
|
PARN
60
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $822K | 0.27% |
385,902
-49,725
| -11% | -$106K |
|
61
Humana
HUM
$37.5B
| $713K | 0.23% |
3,898
-2,800
| -42% | -$512K |
|
62
Vertex Pharmaceuticals
VRTX
$102B
| $696K | 0.23% |
8,750
-9,500
| -52% | -$756K |
|
|
GI
63
DELISTED
EndoChoice Holdings, Inc.
GI
| $681K | 0.22% |
130,763
-93,200
| -42% | -$485K |
|
64
Incyte
INCY
$17B
| $565K | 0.18% |
7,800
+2,100
| +37% | +$152K |
|
65
Merck
MRK
$210B
| $535K | 0.17% |
10,590
-38,147
| -78% | -$1.93M |
|
|
AERI
66
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $525K | 0.17% |
+43,200
| New | +$525K |
|
67
Neurocrine Biosciences
NBIX
$13.5B
| $518K | 0.17% |
+13,100
| New | +$518K |
|
|
TVTY
68
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $517K | 0.17% |
51,211
| – | – |
|
|
ONCE
69
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $516K | 0.17% |
+17,500
| New | +$516K |
|
|
SSRG
70
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $467K | 0.15% |
47,319
-21,014
| -31% | -$207K |
|
71
Perrigo
PRGO
$3.21B
| $461K | 0.15% |
+3,600
| New | +$461K |
|
72
Cardinal Health
CAH
$36B
| $426K | 0.14% |
5,200
-12,300
| -70% | -$1.01M |
|
|
CSLT
73
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $425K | 0.14% |
127,604
-314,904
| -71% | -$1.05M |
|
|
OCRX
74
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $403K | 0.13% |
137,093
| – | – |
|
|
NXTM
75
DELISTED
NxStage Medical Inc.
NXTM
| $396K | 0.13% |
+26,400
| New | +$396K |
|